For more than a century, insulin has saved millions of lives. Yet despite remarkable advances in diabetes technology, one major challenge remains: preventing hypoglycemia while maintaining excellent glucose control. That is why researchers are developing glucose-responsive insulin, often called “smart” insulin. Instead of delivering a fixed amount of insulin regardless …

Imagine screening for diabetes as easily as breathing into a handheld device. That idea is rapidly moving from research laboratories toward clinical reality. Scientists are developing breath tests for diabetes that analyze tiny molecules in exhaled air to identify early metabolic changes long before traditional symptoms develop. Although blood glucose …

Continuous glucose monitoring (CGM) has fundamentally changed diabetes management by giving patients and clinicians access to real-time glucose data. As a result, treatment decisions have become more precise, and many people with diabetes now spend more time within their target glucose range. However, glucose represents only one part of the …

For decades, diabetes management has focused on what patients eat and how much they consume. However, emerging research suggests another factor deserves attention: when they eat. The growing field of chrono-nutrition research in diabetes explores how meal timing interacts with the body’s internal clock to influence glucose metabolism, insulin sensitivity, …

For decades, A1C has served as the gold standard for assessing long-term glucose control in people with diabetes. However, it tells only part of the story. Researchers are now exploring whether metabolic flexibility could become an important biomarker in diabetes, offering a deeper understanding of metabolic health than A1C alone. …

For decades, diabetes has been grouped into familiar categories such as type 1 diabetes, type 2 diabetes, gestational diabetes, and several secondary forms. However, growing international recognition of Type 5 diabetes, formerly known as malnutrition-related diabetes, is challenging long-held assumptions about diabetes classification. This newly recognized condition appears to follow …

For years, artificial sweeteners have been promoted as an important strategy for reducing sugar intake in people with diabetes. They help lower carbohydrate intake, reduce post-meal glucose spikes, and support weight management without adding calories. However, recent research has challenged the long-held assumption that all non-nutritive sweeteners are metabolically neutral. …

Population-based screening for type 1 diabetes is entering a new era. While autoantibody testing remains the gold standard for identifying individuals at high risk, researchers are increasingly investigating whether type 1 diabetes genetic screening could identify susceptible people even earlier. Advances in genomic science now make it possible to estimate …

For more than a century, insulin has been the foundation of type 1 diabetes care. However, even the best insulin pumps, continuous glucose monitors, and automated insulin delivery systems still cannot fully replace the body’s lost beta cells. That is why interest in stem cell islet transplant diabetes research continues …

As demand for GLP-1 receptor agonists continues to outpace supply, many patients have turned to compounded medications obtained through telehealth companies, medical spas, wellness clinics, and compounding pharmacies. While these products may improve access for some individuals, they also introduce important clinical, regulatory, and medicolegal challenges. Providers increasingly encounter patients …